Stocktoria
GLOBUS MEDICAL INC GMED
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2012-03-08
GLOBUS MEDICAL INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | — | — | 65.1% | 74.2% | 75.0% |
| Operating margin | 16.3% | 6.6% | 8.5% | 22.3% | 17.9% |
| Net margin | 18.3% | 4.1% | 7.8% | 18.6% | 15.6% |
| FCF margin | 20.0% | 16.1% | 10.5% | 10.2% | 22.9% |
| Return on assets | 10.1% | 2.0% | 2.4% | 9.2% | 7.6% |
| Return on equity | 11.8% | 2.5% | 3.1% | 10.3% | 8.6% |
| Current ratio | 4.26 | 2.54 | 4.88 | 6.18 | 6.17 |
| Revenue growth | 16.7% | 60.6% | 53.3% | 6.8% | 21.4% |
Source: SEC EDGAR filings · CIK 0001237831 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.